Jonathan Gerber to Leukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a "connection" page, showing publications Jonathan Gerber has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Connection Strength
1.571
-
Patel SA, Bledsoe JR, Higgins AW, Hutchinson L, Gerber JM. Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase. JCO Precis Oncol. 2021 07; 5.
Score: 0.717
-
Gerber JM, Gucwa JL, Esopi D, Gurel M, Haffner MC, Vala M, Nelson WG, Jones RJ, Yegnasubramanian S. Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget. 2013 May; 4(5):715-28.
Score: 0.406
-
Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ. Characterization of chronic myeloid leukemia stem cells. Am J Hematol. 2011 Jan; 86(1):31-7.
Score: 0.346
-
Mitchell M, Itani D, Gerber J, Ghosh N, Gojo I, Zeidan A. Thoracic t(9;22)-positive granulocytic sarcoma as initial presentation of chronic myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):619-21.
Score: 0.102